Selected research
Industry Growth & Trends
Global Cyanocobalamin API Industry Growth and Trends Forecast to 2032
Market perspective
The global Cyanocobalamin API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Cyanocobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Cyanocobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cyanocobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Cyanocobalamin API include Sanofi, Kingvit, North China Pharmaceutical Group, Hebei Yuxing Bio-Engineering, Hebei Huarong Pharmaceutical, GlaxoSmithKline, Wockhardt, Rochem International and EuroAPI, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Cyanocobalamin API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Cyanocobalamin API market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cyanocobalamin API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cyanocobalamin API.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Cyanocobalamin API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Cyanocobalamin API Market by Company
Sanofi
Kingvit
North China Pharmaceutical Group
Hebei Yuxing Bio-Engineering
Hebei Huarong Pharmaceutical
GlaxoSmithKline
Wockhardt
Rochem International
EuroAPI
Bristol Myers Squibb
Basic Nutrition
Antibiotice
Cyanocobalamin API Segment by Type
Crystal
Powder
Cyanocobalamin API Segment by Application
Contract Manufacturing Organizations
Pharmaceutical Companies
Others
Cyanocobalamin API Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyanocobalamin API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cyanocobalamin API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyanocobalamin API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cyanocobalamin API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Cyanocobalamin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Crystal
- Powder
Applications
- Contract Manufacturing Organizations
- Pharmaceutical Companies
- Others
Companies covered
- Sanofi
- Kingvit
- North China Pharmaceutical Group
- Hebei Yuxing Bio-Engineering
- Hebei Huarong Pharmaceutical
- GlaxoSmithKline
- Wockhardt
- Rochem International
- EuroAPI
- Bristol Myers Squibb
- Basic Nutrition
- Antibiotice
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Cyanocobalamin API Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Cyanocobalamin API Sales Estimates and Forecasts (2021-2032)
- 1.3 Cyanocobalamin API Market by Type
- 1.3.1 Crystal
- 1.3.2 Powder
- 1.4 Global Cyanocobalamin API Market Size by Type
- 1.4.1 Global Cyanocobalamin API Market Size Overview by Type (2021-2032)
- 1.4.2 Global Cyanocobalamin API Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Cyanocobalamin API Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Cyanocobalamin API Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Cyanocobalamin API Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Cyanocobalamin API Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Cyanocobalamin API Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Cyanocobalamin API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Cyanocobalamin API Industry Trends
- 2.2 Cyanocobalamin API Industry Drivers
- 2.3 Cyanocobalamin API Industry Opportunities and Challenges
- 2.4 Cyanocobalamin API Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Cyanocobalamin API Revenue (2021-2026)
- 3.2 Global Top Players by Cyanocobalamin API Sales (2021-2026)
- 3.3 Global Top Players by Cyanocobalamin API Price (2021-2026)
- 3.4 Global Cyanocobalamin API Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cyanocobalamin API Major Company Production Sites & Headquarters
- 3.6 Global Cyanocobalamin API Company, Product Type & Application
- 3.7 Global Cyanocobalamin API Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Cyanocobalamin API Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Cyanocobalamin API Players Market Share by Revenue in 2025
- 3.8.3 2025 Cyanocobalamin API Tier 1, Tier 2, and Tier 3
4 Cyanocobalamin API Regional Status and Outlook
- 4.1 Global Cyanocobalamin API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Cyanocobalamin API Historic Market Size by Region
- 4.2.1 Global Cyanocobalamin API Sales in Volume by Region (2021-2026)
- 4.2.2 Global Cyanocobalamin API Sales in Value by Region (2021-2026)
- 4.2.3 Global Cyanocobalamin API Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Cyanocobalamin API Forecasted Market Size by Region
- 4.3.1 Global Cyanocobalamin API Sales in Volume by Region (2027-2032)
- 4.3.2 Global Cyanocobalamin API Sales in Value by Region (2027-2032)
- 4.3.3 Global Cyanocobalamin API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cyanocobalamin API by Application
- 5.1 Cyanocobalamin API Market by Application
- 5.1.1 Contract Manufacturing Organizations
- 5.1.2 Pharmaceutical Companies
- 5.1.3 Others
- 5.2 Global Cyanocobalamin API Market Size by Application
- 5.2.1 Global Cyanocobalamin API Market Size Overview by Application (2021-2032)
- 5.2.2 Global Cyanocobalamin API Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Cyanocobalamin API Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Cyanocobalamin API Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Cyanocobalamin API Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Cyanocobalamin API Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Cyanocobalamin API Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Cyanocobalamin API Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Sanofi
- 6.1.1 Sanofi Company Information
- 6.1.2 Sanofi Business Overview
- 6.1.3 Sanofi Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Sanofi Cyanocobalamin API Product Portfolio
- 6.1.5 Sanofi Recent Developments
- 6.2 Kingvit
- 6.2.1 Kingvit Company Information
- 6.2.2 Kingvit Business Overview
- 6.2.3 Kingvit Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Kingvit Cyanocobalamin API Product Portfolio
- 6.2.5 Kingvit Recent Developments
- 6.3 North China Pharmaceutical Group
- 6.3.1 North China Pharmaceutical Group Company Information
- 6.3.2 North China Pharmaceutical Group Business Overview
- 6.3.3 North China Pharmaceutical Group Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 North China Pharmaceutical Group Cyanocobalamin API Product Portfolio
- 6.3.5 North China Pharmaceutical Group Recent Developments
- 6.4 Hebei Yuxing Bio-Engineering
- 6.4.1 Hebei Yuxing Bio-Engineering Company Information
- 6.4.2 Hebei Yuxing Bio-Engineering Business Overview
- 6.4.3 Hebei Yuxing Bio-Engineering Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Hebei Yuxing Bio-Engineering Cyanocobalamin API Product Portfolio
- 6.4.5 Hebei Yuxing Bio-Engineering Recent Developments
- 6.5 Hebei Huarong Pharmaceutical
- 6.5.1 Hebei Huarong Pharmaceutical Company Information
- 6.5.2 Hebei Huarong Pharmaceutical Business Overview
- 6.5.3 Hebei Huarong Pharmaceutical Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Hebei Huarong Pharmaceutical Cyanocobalamin API Product Portfolio
- 6.5.5 Hebei Huarong Pharmaceutical Recent Developments
- 6.6 GlaxoSmithKline
- 6.6.1 GlaxoSmithKline Company Information
- 6.6.2 GlaxoSmithKline Business Overview
- 6.6.3 GlaxoSmithKline Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 GlaxoSmithKline Cyanocobalamin API Product Portfolio
- 6.6.5 GlaxoSmithKline Recent Developments
- 6.7 Wockhardt
- 6.7.1 Wockhardt Company Information
- 6.7.2 Wockhardt Business Overview
- 6.7.3 Wockhardt Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Wockhardt Cyanocobalamin API Product Portfolio
- 6.7.5 Wockhardt Recent Developments
- 6.8 Rochem International
- 6.8.1 Rochem International Company Information
- 6.8.2 Rochem International Business Overview
- 6.8.3 Rochem International Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Rochem International Cyanocobalamin API Product Portfolio
- 6.8.5 Rochem International Recent Developments
- 6.9 EuroAPI
- 6.9.1 EuroAPI Company Information
- 6.9.2 EuroAPI Business Overview
- 6.9.3 EuroAPI Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 EuroAPI Cyanocobalamin API Product Portfolio
- 6.9.5 EuroAPI Recent Developments
- 6.10 Bristol Myers Squibb
- 6.10.1 Bristol Myers Squibb Company Information
- 6.10.2 Bristol Myers Squibb Business Overview
- 6.10.3 Bristol Myers Squibb Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Bristol Myers Squibb Cyanocobalamin API Product Portfolio
- 6.10.5 Bristol Myers Squibb Recent Developments
- 6.11 Basic Nutrition
- 6.11.1 Basic Nutrition Company Information
- 6.11.2 Basic Nutrition Business Overview
- 6.11.3 Basic Nutrition Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Basic Nutrition Cyanocobalamin API Product Portfolio
- 6.11.5 Basic Nutrition Recent Developments
- 6.12 Antibiotice
- 6.12.1 Antibiotice Company Information
- 6.12.2 Antibiotice Business Overview
- 6.12.3 Antibiotice Cyanocobalamin API Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Antibiotice Cyanocobalamin API Product Portfolio
- 6.12.5 Antibiotice Recent Developments
7 North America by Country
- 7.1 North America Cyanocobalamin API Sales by Country
- 7.1.1 North America Cyanocobalamin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Cyanocobalamin API Sales by Country (2021-2026)
- 7.1.3 North America Cyanocobalamin API Sales Forecast by Country (2027-2032)
- 7.2 North America Cyanocobalamin API Market Size by Country
- 7.2.1 North America Cyanocobalamin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Cyanocobalamin API Market Size by Country (2021-2026)
- 7.2.3 North America Cyanocobalamin API Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Cyanocobalamin API Sales by Country
- 8.1.1 Europe Cyanocobalamin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Cyanocobalamin API Sales by Country (2021-2026)
- 8.1.3 Europe Cyanocobalamin API Sales Forecast by Country (2027-2032)
- 8.2 Europe Cyanocobalamin API Market Size by Country
- 8.2.1 Europe Cyanocobalamin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Cyanocobalamin API Market Size by Country (2021-2026)
- 8.2.3 Europe Cyanocobalamin API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Cyanocobalamin API Sales by Country
- 9.1.1 Asia-Pacific Cyanocobalamin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Cyanocobalamin API Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Cyanocobalamin API Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Cyanocobalamin API Market Size by Country
- 9.2.1 Asia-Pacific Cyanocobalamin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Cyanocobalamin API Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Cyanocobalamin API Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Cyanocobalamin API Sales by Country
- 10.1.1 South America Cyanocobalamin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Cyanocobalamin API Sales by Country (2021-2026)
- 10.1.3 South America Cyanocobalamin API Sales Forecast by Country (2027-2032)
- 10.2 South America Cyanocobalamin API Market Size by Country
- 10.2.1 South America Cyanocobalamin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Cyanocobalamin API Market Size by Country (2021-2026)
- 10.2.3 South America Cyanocobalamin API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Cyanocobalamin API Sales by Country
- 11.1.1 Middle East and Africa Cyanocobalamin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Cyanocobalamin API Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Cyanocobalamin API Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Cyanocobalamin API Market Size by Country
- 11.2.1 Middle East and Africa Cyanocobalamin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Cyanocobalamin API Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Cyanocobalamin API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Cyanocobalamin API Value Chain Analysis
- 12.1.1 Cyanocobalamin API Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Cyanocobalamin API Production Mode & Process
- 12.2 Cyanocobalamin API Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Cyanocobalamin API Distributors
- 12.2.3 Cyanocobalamin API Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst